Machine Learning Analysis of Two-photon Fluorescence Microscopy of Dermatologic Biopsies
Part of paid clinical trials in Victor, New York.
- Sponsor
- University of Rochester
- Study ID
- NCT07682831
- Status
- Recruiting
Conditions
- Basal Cell Carcinoma of Skin
- Squamous Cell Carcinoma (Skin)
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Two photon microscopy imaging — DEVICEEx vivo tissues will be imaged with two-photon microscopy and analyzed with machine learning for diagnosis
Study Details
The goal of this study is to investigate the ability of a machine learning model to evaluate two-photon fluorescence microscopy images of dermatologic biopsies at point of care. The main question it aims to answer is: • How well do two-photon fluorescence images of biopsies taken in a clinic and evaluated by a machine learning model agree with conventional histology?
Key Dates
- First listed
- Jul 6, 2026
- Start date
- Jun 24, 2026
- Status verified
- Aug 2026
- Primary completion
- Jun 1, 2027
- Completion
- Jul 1, 2027
Study Design
- Enrollment
- 92 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: TPFM imaging of biopsySpecimens will be imaged with TPFM and diagnosed using a machine learning model
Primary Outcome Measure
Sensitivity of Machine Learning Analysis of Two Photon Fluorescence Microscopy Images At Point of Care [ Time Frame: During or immediately following patient biopsy (same day) ]
Central Contacts
- Michael Giacomelli, Ph.D5852766260
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Rochester Dermatologic Surgery | Victor | New York | 14654 |
Find similar trials in Victor, NY
By research site
Related Studies
- Two-photon Fluorescence Microscopy of Dermatologic BiopsiesRecruiting · University of Rochester · Victor, New York
- A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid TumorsPHASE1/PHASE2 · Recruiting · AstraZeneca · Grand Rapids, Michigan